Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Can J Cardiol. 2022 May;38(5):681-687. doi: 10.1016/j.cjca.2022.01.029. Epub 2022 Feb 3.
Resistant hypertension is associated with cardiovascular morbidity and mortality. The objective of this study was to estimate the prevalence of apparent treatment-resistant hypertension in Canadian adults and examine the characteristics of those affected.
A nationally representative cross-sectional study was conducted with the use of Canadian Health Measures Survey (2007-2017) data. The frequency of respondents with uncontrolled blood pressure despite 3 or more antihypertensive medications of different drug classes (and at least 1 agent being a diuretic), or treatment with 4 or more agents regardless of blood pressure, was determined.
A total of 245,700 people were identified to have apparent treatment-resistant hypertension, representing 5.3% (95% confidence interval [CI] 4.5%-6.2%) of adults treated for hypertension in Canada. Respondents who had uncontrolled blood pressure with 3 or more antihypertensive drugs were more likely women (55.8%, 95% CI 41.1%-70.4%), 70 years of age or older (45.3% 95% CI 32.8%-57.9%), and overweight or obese (84.2%, 95% CI 72.3%-96.1%). Respondents with apparent treatment-resistant hypertension also had a high likelihood of chronic kidney disease (36.0%, 95% CI 21.4%-50.6%), diabetes (35.2%, 95% CI 21.7%-48.7%), dyslipidemia (68.0%, 95% CI 55.2%-80.8%), and history of heart attack (9.9%, 95% CI 4.8%-15.1%) or stroke (7.1%, 95% CI 0-14.4%).
Despite being prescribed at least 3 antihypertensive drugs, a considerable proportion of Canadians, especially women, have difficulty achieving blood pressure control, predisposing them to a higher risk of cardiovascular complications and death.
抗药性高血压与心血管发病率和死亡率有关。本研究的目的是估计加拿大成年人中明显抗药性高血压的患病率,并研究受其影响的人群的特征。
本研究使用加拿大健康测量调查(2007-2017 年)的数据进行了一项全国代表性的横断面研究。确定尽管使用了 3 种或更多不同类别的降压药物(至少有一种利尿剂),或无论血压如何使用 4 种或更多药物治疗,但血压仍未得到控制的受访者的频率。
共确定了 245700 人患有明显的抗药性高血压,占加拿大接受高血压治疗的成年人的 5.3%(95%置信区间[CI] 4.5%-6.2%)。血压控制不佳且使用 3 种以上降压药物的受访者更可能是女性(55.8%,95% CI 41.1%-70.4%),年龄在 70 岁或以上(45.3%,95% CI 32.8%-57.9%),超重或肥胖(84.2%,95% CI 72.3%-96.1%)。患有明显抗药性高血压的患者也有很高的慢性肾脏病(36.0%,95% CI 21.4%-50.6%)、糖尿病(35.2%,95% CI 21.7%-48.7%)、血脂异常(68.0%,95% CI 55.2%-80.8%)和心脏病发作史(9.9%,95% CI 4.8%-15.1%)或中风(7.1%,95% CI 0-14.4%)的可能性。
尽管至少开了 3 种降压药,但相当一部分加拿大人,尤其是女性,血压控制困难,使他们更容易发生心血管并发症和死亡的风险增加。